The biological role of the Fas/FasL system during tumor formation and progression
- 29 July 2002
- journal article
- review article
- Published by Elsevier in Seminars in Cancer Biology
- Vol. 12 (4) , 309-315
- https://doi.org/10.1016/s1044-579x(02)00017-2
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Fas-dependent tissue turnover is implicated in tumor cell clearanceOncogene, 2000
- Safety and antitumor activity of recombinant soluble Apo2 ligandJournal of Clinical Investigation, 1999
- Caspases: killer proteasesTrends in Biochemical Sciences, 1997
- CD95-Induced Apoptosis of Lymphocytes in an Immune Privileged Site Induces Immunological ToleranceImmunity, 1996
- Fas and Fas ligand in embryos and adult mice: ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover.The Journal of cell biology, 1996
- Fas Ligand-Induced Apoptosis as a Mechanism of Immune PrivilegeScience, 1995
- A role for CD95 ligand in preventing graft rejectionNature, 1995
- Regulation of cell surface APO‐1/Fas (CD95) ligand expression by metalloproteasesEuropean Journal of Immunology, 1995
- Molecular cloning and expression of the fas ligand, a novel member of the tumor necrosis factor familyCell, 1993
- A novel domain within the 55 kd TNF receptor signals cell deathCell, 1993